The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases

被引:104
|
作者
Sitaru, Cassian [1 ]
Mihai, Sidonia [1 ]
Zillikens, Detlef [1 ]
机构
[1] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany
关键词
autoimmune bullous diseases; IgG subclasses; complement;
D O I
10.1007/s00403-007-0734-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Autoimmune bullous skin diseases are characterized by autoantibodies and T cells specific to structural proteins maintaining cell-cell and cell-matrix adhesion in the skin. Existing clinical and experimental evidence generally supports a pathogenic role of autoantibodies for blister formation. These autoantibodies belong to several IgG subclasses, which associate with different functional properties and may thus determine the pathogenic potential of IgG antibodies. In pemphigus diseases, binding of IgG to keratinocytes is sufficient to cause intraepidermal blisters without engaging innate immune effectors and IgG4 autoantibodies seem to mainly mediate acantholysis. In contrast, in most subepidermal autoimmune blistering diseases, complement activation and recruitment and activation of leukocytes by autoantibodies are required for blister induction. In these conditions, tissue damage is thought to be mainly mediated by IgG1, but not IgG4 autoantibodies. This review summarizes the current knowledge on the pathogenic relevance of the IgG subclass of autoantibodies for blister formation. Characterization of the pathogenically relevant subclass(es) of autoantibodies not only provides mechanistic insights, but should greatly facilitate the development of improved therapeutic modalities of autoimmune blistering diseases.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] IGG SUBCLASS DISTRIBUTION OF THYROGLOBULIN AUTOANTIBODIES IN JUVENILES AND ADULTS WITH AUTOIMMUNE THYROID-DISEASE
    BUREK, CL
    OUTSCHOORN, JO
    ROSE, NR
    [J]. FASEB JOURNAL, 1988, 2 (06): : A1671 - A1671
  • [32] Quantitation of erythrocyte-bound IgG subclass autoantibodies in murine autoimmune haemolytic anaemia
    Mazza, G
    Day, MJ
    Barker, RN
    Corato, A
    Elson, CJ
    [J]. AUTOIMMUNITY, 1996, 23 (04) : 245 - 255
  • [33] Clinical, histopathologic, and therapeutic aspects of subepidermal autoimmune bullous diseases with IgG on the floor of salt-split skin
    Barnadas, MA
    González, J
    Planagumà, M
    Romaní, J
    Curell, R
    de Moragas, JM
    Alomar, A
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (04) : 268 - 272
  • [34] Patterns of tissue-bound antiepidermal autoantibodies in bullous skin diseases
    Büchner, L
    [J]. PATHOGENIC AND DIAGNOSTIC RELEVANCE OF AUTOANTIBODIES, 1998, 9 : 200 - 203
  • [35] Anti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous Diseases
    Tampoia, Marilina
    Zucano, Antonietta
    Villalta, Danilo
    Antico, Antonio
    Bizzaro, Nicola
    [J]. DERMATOLOGY, 2012, 225 (01) : 37 - 44
  • [36] Recent advancement on autoantigens, autoantibodies and inflammatory cells in subepidermal autoimmune bullous diseases
    Jianguo Huang
    Department of Dermatology
    [J]. The Journal of Biomedical Research, 2007, (03) : 129 - 133
  • [37] Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting
    Oyama, N
    Bhogal, BS
    Carrington, P
    Gratian, MJ
    Black, MM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (05) : 939 - 944
  • [38] Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases
    Bornscheuer, E
    Zillkens, D
    Schröder, JM
    Sticherling, M
    [J]. DERMATOLOGY, 1999, 198 (02) : 118 - 121
  • [39] Autoimmune bullous skin diseases. Part 2: diagnosis and therapy
    Kneisel, Andrea
    Hertl, Michael
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (11): : 927 - 947
  • [40] Autoimmune bullous skin diseases. Part 1: Clinical manifestations
    Kneisel, Andrea
    Hertl, Michael
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (10): : 844 - 857